Medigene AG: Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act)

Medigene AG / Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act) . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.

Details of the person subject to the disclosure requirement
Name:	Llewellyn-Davies,  Peter
Professional role:	Person with executive functions:   Member of a managing body
Details of the relationship:	CFO
Â	Â
Designation of the financial instrument
ISIN:	DE000A11QVD8
Designation:	MEDIGENE AG NA O.N.JGE
Â	Â
Details of the transaction
Type of transaction:	Purchase
Date:	22.07.2014
Place (stock exchange):	Frankfurt
Price:	5.00
Currency:	EUR
Quantity:	428
Business volume:	2140
Additional details:	Referring to subscription right
Â	Â
Details of the company with the publishing obligation:
Issuer:
Medigene AG
Lochhamer Strasse 11
D-82152   Martinsried / München
Germany

ISIN:	DE000A1X3W00
WKN:	A1X3W0

---

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Medigene AG via Globenewswire

HUG#1840410

--- End of Message ---

Medigene AG
Lochhamer Strasse 11 Martinsried / München Germany

WKN: A1X3W0;ISIN: DE000A1X3W00;
Listed: Freiverkehr in Börse Stuttgart,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg,
Freiverkehr in Börse Berlin,
Freiverkehr in Börse Düsseldorf,
Freiverkehr in Bayerische Börse München,
Freiverkehr in Niedersächsische Börse zu Hannover,
Prime Standard in Frankfurter Wertpapierbörse,
Regulierter Markt in Frankfurter Wertpapierbörse;